Aakaar Medical Technologies Ltd Financials
Company Logo

Aakaar Medical Technologies Ltd Financial Statement

Aakaar Medical Technologies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Aakaar Medical Technologies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual61.58
Operating Expenses Annual51.85
Operating Profit Annual9.91
Interest Annual1.71
Depreciation0.12
Net Profit Annual6.04
Tax Annual2.04

Aakaar Medical Technologies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.30
Cash Flow from Operations-5.41
Cash Flow from Investing-0.05
Cash Flow from Financing10.71
Cash Flow at the End5.55

Aakaar Medical Technologies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)16.11
PBIT Margin (%)15.91
PBT Margin (%)6.61
Net PROFIT Margin (%)9.81
Return On Networth / Equity (%)33.80
Return On Networth /Employed (%)26
Return On Assets (%)16.09
Total Debt / Equity (X)1.06
Asset Turnover Ratio (%)1.64

Aakaar Medical Technologies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual0.24
Total Current Assets Annual51.85
Non Current Assets Annual2.25
Total Shareholders Funds Annual23.20
Total Assets Annual54.10

Aakaar Medical Technologies Ltd Earning Calls

No Data Availabe

FAQS on Aakaar Medical Technologies Ltd Financials

As of Jun 27, 2025, Aakaar Medical Technologies Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Aakaar Medical Technologies Ltd is not with a debt-to-equity ratio of 0.98.

In FY 2024 , Aakaar Medical Technologies Ltd recorded a total revenue of approximately 61.58 Cr marking a significant milestone in the company's financial performance.

Aakaar Medical Technologies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.3% annually, respectively..

Aakaar Medical Technologies Ltd's current PE ratio is .

Aakaar Medical Technologies Ltd's ROCE averaged 20.8% from the FY ending March 2023 to 2025, with a median of 21.3%. It peaked at 22.7% in March 2023, reflecting strong capital efficiency over the period..

Aakaar Medical Technologies Ltd's latest EBIT is Rs. 9.79 Cr, surpassing the average EBIT of Rs. 6.12 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions